QTTB
Q32 Bio Inc.
NASDAQ · Healthcare · Biotechnology · US
$11.99
−6.33%Margins
Gross margin
99.8%
EBITDA margin
64.4%
EBIT margin
39.9%
Net margin
62.9%
FCF margin
-36.9%
31.9%
Return on equity
29.2%
Return on assets
19.3%
Return on invested capital
0.60x
Asset turnover
-$19.8M
Cash from operations
$3.57
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026